Company Filing History:
Years Active: 2019
Title: Innovations of Chiung-Yi Chiu in Cancer Research
Introduction
Chiung-Yi Chiu is a notable inventor based in Douliu, Taiwan. He has made significant contributions to the field of cancer research, particularly through his innovative work on antibodies that target specific receptors involved in tumor growth.
Latest Patents
Chiung-Yi Chiu holds a patent for an anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibody. This patent describes methods for detecting VEGFR2 and for inhibiting tumor growth, tumor angiogenesis, and inducing cancer cell cytotoxicity. The isolated antibody or its antigen-binding fragment has a specific binding affinity to an epitope located within the domain 1 or domain 3 of human VEGFR2. The epitope within domain 3 is specifically located between amino acid residues 250 and 270 of SEQ ID NO: 74. The patent also outlines the use of this antibody in the manufacture of a medicament aimed at inhibiting tumor growth and angiogenesis in subjects in need.
Career Highlights
Chiung-Yi Chiu is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has been pivotal in advancing the understanding of cancer biology and developing therapeutic strategies against cancer.
Collaborations
Chiung-Yi Chiu has collaborated with notable colleagues such as Han-Chung Wu and Ruei-Min Lu. Their joint efforts have contributed to the advancement of research in the field of cancer treatment.
Conclusion
Chiung-Yi Chiu's innovative work in developing targeted therapies against cancer exemplifies the critical role of inventors in advancing medical science. His contributions continue to impact the field significantly.